Abstract
The effects of ovulation inhibitors on aspects of glucose metabolism are reviewed. In sequential and combined preparations, studies suggest that both the estrogen and the progestin components may affect fasting blood sugar, oral glucose tolerance, and serum insulin levels. The changes which have been reported are not large in metabolically healthy women, however, and do not contraindicate oral contraceptives for these women. Oral glucose tolerance should be checked before prescribing oral contraceptives to women with diabetic risk factors. Diabetic women must be carefully supervised during oral contraception.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
